Src I1

• Background :

  SrcI1 is a potent and competitive dual site Src kinase inhibitor. It has been shown as a potent inhibitor of the Src and Lck kinase, as well as, VEGFR2 and c-fms. SrcI1 is cell permeable and can induce apoptosis.

• Description :

  Src kinase inhibitor

• Product Name Alternative :

  6,7-Dimethoxy-N- (4-phenoxyphenyl) -4-quinazolinamine, SKI-1, Src Inhibitor-1

• UNSPSC :

  41116105

• Type :

  Inhibitor

• Source :

  Synthetic

• Field of Research :

  Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors

• Purity :

  ≥98% (TLC)

• Weight :

  0.025

• Format :

  Off-white solid

• Solubility :

  Soluble in DMSO (5 mg/ml)

• Molecular Formula :

  C22H19N3O3

• Molecular Weight :

  373.4

• Precautions :

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• References & Citations :

  1. Bain, J., et al. (2007) Biochem. J. 408(3): 297–315. 2. Leung, E. L.H., et al. (2009) Mol. Cancer. Res: MCR. 7(6): 923–932.

• CAS Number :

  179248-59-0